THALAGEN
DEAD

Serial Number

85060357

Owner

Errant Gene Therapeutics, LLC

Attorney

Daliah Saper

First Use Date

Aug 2, 2010

Filing Date

Jun 11, 2010

Add to watchlist:

No watchlists yet
View on USPTO

THALAGEN Trademark

Serial Number: 85060357 • Registration: 4023649

THALAGEN is a trademark filed by Errant Gene Therapeutics, LLC on June 11, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Errant Gene Therapeutics, LLC (5 trademarks)

200 West Jackson Boulevard, Suite 2400
Chicago, IL 60606

Entity Type: 99

Trademark Details

Filing Date

June 11, 2010

Registration Date

September 6, 2011

First Use Anywhere

August 2, 2010

First Use in Commerce

August 2, 2010

Published for Opposition

November 23, 2010

Cancellation Date

April 13, 2018

Goods & Services

Pharmaceutical products and preparations in the form of a suspension intravenously administered to the patients for the treatment of thalassemia and sickle cell anemia, for use in connection with bone marrow transplants

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 13, 2018 C8..
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2011 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 2, 2011 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Aug 1, 2011 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 1, 2011 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jul 26, 2011 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 26, 2011 AITU
USE AMENDMENT FILED
Jul 15, 2011 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 15, 2011 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 18, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 20, 2010 PREV
ASSIGNED TO LIE
Oct 20, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2010 CNSA
ASSIGNED TO EXAMINER
Sep 21, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2010 NWOS
NEW APPLICATION ENTERED
Jun 15, 2010 NWAP